Article
p38α‐MAPK‐deficient myeloid cells ameliorate symptoms and pathology of APP ‐transgenic Alzheimer's disease mice
31 Jul 2022
Abstract excerpt
Alzheimer's disease (AD), the most common cause of dementia in the elderly, is pathologically characterized by extracellular deposition of amyloid-β peptides (Aβ) and microglia-dominated inflammatory activation in the brain. p38α-MAPK is activated in both neurons and microglia. How p38α-MAPK in microglia contributes to AD pathogenesis remains unclear. In this study, we conditionally knocked out p38α-MAPK in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
